Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Asha Das
Eisai Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. Robert Jotte
Denver, Colorado, United States
- Melbourne Internal Medicine Associates
Melbourne, Florida, United States
- Ocala Oncology Center Pl
Ocala, Florida, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Minnesota Hematology Oncology
Burnsville, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- New York Oncology Hematology, P.C.
Albany, New York, United States
- Columbia University Medical Center
New York, New York, United States
- St. Luke'S Roosevelt Hospital Center
New York, New York, United States
- Raleigh Hematology Oncology Associates Pl
Raleigh, North Carolina, United States
- Mary Crowley Medical Research Center
Dallas, Texas, United States
- Us Oncology
Dallas, Texas, United States
- El Paso Cancer Treatment Center
El Paso, Texas, United States
- Texas Oncology Pa
Fort Worth, Texas, United States
- Texas Oncology Pa
Tyler, Texas, United States
- Tyler Cancer Center
Tyler, Texas, United States
- Deke Slayton Cancer Center
Webster, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- 31 Jan 2008
- Completion
- 31 Jan 2008
- Last update posted
- 14 Jul 2014
- Registered enrollment
- 108
- Registry id
- NCT00278993
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.